Closed · W81XWH-22-ERP-IDA · CFDA 12.420 · Discretionary
DOD Epilepsy, Idea Development Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- June 23, 2022
- Close date
- 6
- Expected awards
The verdict
DOD Epilepsy, Idea Development Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 6 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 6
- expected awards
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DOD Epilepsy, Idea Development Award - is cataloged under number W81XWH-22-ERP-IDA and tied to CFDA assistance listing 12.420, posted by Defense Health Agency Contracting Activity - DHACA. Grants.gov currently shows the opportunity as closed, first posted on March 18, 2022. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. The agency has projected $4.1 million in total estimated funding for this announcement. It expects to issue 6 awards. If the agency funds the expected 6 awards from the $4.1 million estimated pool, the average award works out to roughly $680,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on June 23, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
June 23, 2022
Posted
March 18, 2022
Est. Total Funding
$4,080,000
Expected Awards
6
Instrument
Grant
Description
The intent of the FY22 ERP IDA is to solicit novel, innovative research that has the potential to increase our understanding of post-traumatic epilepsy to improve quality of life, especially in Service Members, Veterans, and/or their care partners. The work should innovatively challenge existing research paradigms or exhibit high levels of creativity. The FY22 ERP IDA offers two levels of funding dependent upon the level of experience of the Principal Investigator (PI):• Funding Level I - Pathway to Independence Option – open to postdoctoral fellows or investigators within 3 years of their first independent faculty position (or equivalent)• Funding Level II - Innovative New Direction Option – open to independent investigators at or above the level of assistant professor (or equivalent)Funding levels are contingent upon meeting the eligibility requirements described in Section II.C, Eligibility Information.Important aspects of this award mechanism include:• Impact: Applications should articulate the short- and long-term impact of the proposed research on the PTE research field, patient care, and those living with PTE. Projects should address one or more of the FY22 ERP Focus Areas or provide a strong justification as to why the alternative topic is critical to advance understanding of PTE and addresses the ERP mission. Applicants are encouraged to consult with individuals living with PTE during the development and execution of the proposed research project, to ensure research outcomes maximize translational and impact potential.• Innovation: Applications should propose innovative ideas or approaches to address questions relevant to PTE. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities.• Relevance to Military Health: Projects must be relevant to military Service Members, their families, and Veterans with PTE. Collaboration with military and VA researchers and clinicians is encouraged.• Experience in PTE Research: The PI on the application can be from any field or discipline; however, it is CRITICAL that the application demonstrate the study team’s experience in PTE research, including expertise in the fields of BOTH TBI and epilepsy.Preliminary data are encouraged but NOT required. Although preliminary data are not required, evidence demonstrating the ability of the applicant to execute the chosen model of TBI within their laboratory or the laboratory of a collaborator is required.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |